XML 33 R19.htm IDEA: XBRL DOCUMENT v3.26.1
RESTRUCTURING COSTS
 6 Months Ended
Jun. 27, 2026
Restructuring and Related Activities [Abstract]  
RESTRUCTURING COSTS
10. RESTRUCTURING COSTS

During 2025 and 2026, the Company initiated certain business restructuring activities aimed at improving operational efficiency and aligning resources with strategic priorities. These activities resulted in restructuring charges primarily related to (i) an internal reorganization, combining two complementary divisions into one and realigning our customer-facing organization, which occurred in the fourth quarter of 2024, (ii) commencing in the second quarter of 2025, workforce reductions and the abandonment of certain capital equipment no longer necessary for the Company’s long-term objectives, and (iii) actions that occurred in the second quarter of 2026 associated with the wind-down of the Company’s Life Sciences Fluid Management business, which includes the planned closure of a manufacturing facility. These restructuring activities are deemed to be discrete initiatives that are different from the Company’s ongoing productivity improvements.

The charges related to these restructuring activities were recognized in the condensed consolidated statements of operations for the three and six months ended June 27, 2026 and June 28, 2025 and were as follows:
Three months ended June 27, 2026Three months ended June 28, 2025
(In millions)Employee Termination BenefitsAsset Impairment ChargesTotalEmployee Termination BenefitsAsset Impairment ChargesTotal
Cost of sales$0.2 $— $0.2 $2.1 $— $2.1 
Selling, general and administrative1.1 3.8 4.9 3.4 6.3 9.7 
Engineering, research and development0.5 — 0.5 1.5 — 1.5 
Total$1.8 $3.8 $5.6 $7.0 $6.3 $13.3 

Six months ended June 27, 2026Six months ended June 28, 2025
(In millions)Employee Termination BenefitsAsset Impairment ChargesTotalEmployee Termination BenefitsAsset Impairment ChargesTotal
Cost of sales$0.5 $— $0.5 $2.3 $— $2.3 
Selling, general and administrative4.2 3.8 8.0 5.0 6.3 11.3 
Engineering, research and development1.2 — 1.2 2.1 — 2.1 
Total$5.9 $3.8 $9.7 $9.4 $6.3 $15.7 

Restructuring charges by reportable segment as well as unallocated corporate level charges for the three and six months ended June 27, 2026 and June 28, 2025 were as follows:
Three months ended June 27, 2026Three months ended June 28, 2025
(In millions)Employee Termination BenefitsAsset Impairment ChargesTotalEmployee Termination BenefitsAsset Impairment ChargesTotal
MS$— $— $— $3.0 $— $3.0 
APS1.1 3.8 4.9 3.6 6.3 9.9 
Unallocated corporate0.7 — 0.7 0.4 — 0.4 
Total$1.8 $3.8 $5.6 $7.0 $6.3 $13.3 

Six months ended June 27, 2026Six months ended June 28, 2025
(In millions)Employee Termination BenefitsAsset Impairment ChargesTotalEmployee Termination BenefitsAsset Impairment ChargesTotal
MS$1.2 $— $1.2 $3.1 $— $3.1 
APS2.6 3.8 6.4 5.9 6.3 12.2 
Unallocated corporate2.1 — 2.1 0.4 — 0.4 
Total$5.9 $3.8 $9.7 $9.4 $6.3 $15.7